Rachael M. Jones

Dr. Rachael M. Jones


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Environment International
Verified
Journal Article
Open access
STSong Tang
Song Tang
Yixin MaoYixin Mao
Yixin Mao
RJRachael M. Jones
Rachael M. Jones
QTQiyue Tan
Qiyue Tan
JJJohn S Ji
John S Ji
XSXiaoming Shi
Xiaoming Shi
• Evidence suggests the transmission of SARS-CoV-2 via aerosols is plausible under favorable conditions. • We synthesized the evidence for aerosol transmission and highlight the scenarios where SARS-CoV-2 aerosols may be pertinent to transmission. • We summarize precautions and infection control strategies to mitigate aerosol transmission of SARS-CoV-2.

1 May 2015 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Closed access
RJRachael M. Jones
Rachael M. Jones
LBLisa M. Brosseau
Lisa M. Brosseau
The concept of aerosol transmission is developed to resolve limitations in conventional definitions of airborne and droplet transmission. The method was literature review. An infectious aerosol is a collection of pathogen-laden particles in air. Aerosol particles may deposit onto or be inhaled by a susceptible person. Aerosol transmission is biologically plausible when infectious aerosols are generated by or from an infectious person, the pathogen remains viable in the environment for some period of time, and the target tissues in which the pathogen initiates infection are accessible to the aerosol. Biological plausibility of aerosol transmission is evaluated for Severe Acute Respiratory Syndrome coronavirus and norovirus and discussed for Mycobacterium tuberculosis, influenza, and Ebola virus. Aerosol transmission reflects a modern understanding of aerosol science and allows physically appropriate explanation and intervention selection for infectious diseases.

17 August 2009 in Risk Analysis
Verified
Journal Article
Closed access
PDF file
MNMark Nicas
Mark Nicas
RJRachael M. Jones
Rachael M. Jones

9 January 2018 in Environmental Health
Verified
Journal Article
Open access
PDF file
SDStephanie DeFlorio-Barker
Stephanie DeFlorio-Barker
CWCoady Wing
Coady Wing
RJRachael M. Jones
Rachael M. Jones
SDSamuel Dorevitch
Samuel Dorevitch
Activities such as swimming, paddling, motor-boating, and fishing are relatively common on US surface waters. Water recreators have a higher rate of acute gastrointestinal illness, along with other illnesses including respiratory, ear, eye, and skin symptoms, compared to non-water recreators. The quantity and costs of such illnesses are unknown on a national scale. Recreational waterborne illness incidence and severity were estimated using data from prospective cohort studies of water recreation, reports of recreational waterborne disease outbreaks, and national water recreation statistics. Costs associated with medication use, healthcare provider visits, emergency department (ED) visits, hospitalizations, lost productivity, long-term sequelae, and mortality were aggregated. An estimated 4 billion surface water recreation events occur annually, resulting in an estimated 90 million illnesses nationwide and costs of $2.2- $3.7 billion annually (central 90% of values). Illnesses of moderate severity (visit to a health care provider or ED) were responsible for over 65% of the economic burden (central 90% of values: $1.4- $2.4 billion); severe illnesses (result in hospitalization or death) were responsible for approximately 8% of the total economic burden (central 90% of values: $108- $614 million). Recreational waterborne illnesses are associated with a substantial economic burden. These findings may be useful in cost-benefit analysis for water quality improvement and other risk reduction initiatives.

1 January 2017 in Environmental Research
Verified
Journal Article
Closed access
LSLeslie Thomas Stayner
Leslie Thomas Stayner
KAKirsten Almberg
Kirsten Almberg
RJRachael M. Jones
Rachael M. Jones
JGJudith Graber
Judith Graber
MPMarie Pedersen
Marie Pedersen
MTMary Turyk
Mary Turyk

10 July 2019 in Journal of Occupational and Environmental Hygiene
Verified
Journal Article
Closed access
LPLinh T. Phan
Linh T. Phan
DMDayana Maita
Dayana Maita
DMDonna C. Mortiz
Donna C. Mortiz
RWRachel Weber
Rachel Weber
CFCharissa Fritzen-Pedicini
Charissa Fritzen-Pedicini
FPFor The Cdc Prevention Epicenters Program
For The Cdc Prevention Epicenters Program
During the doffing of personal protective equipment (PPE), pathogens can be transferred from the PPE to the bodies of healthcare workers (HCWs), putting HCWs and patients at risk of exposure and infection. PPE doffing practices of HCWs who cared for patients with viral respiratory infections were observed at an acute care hospital from March 2017 to April 2018. A trained observer recorded doffing performance of HCWs inside the patient rooms using a pre-defined checklist based on the Centers for Disease Control and Prevention (CDC) guideline. Doffing practices were observed 162 times during care of 52 patients infected with respiratory viral pathogens. Out of the 52 patients, 30 were in droplet and contact isolation, 21 were in droplet isolation, and 1 was in contact isolation. Overall, 90% of observed doffing was incorrect, with respect to the doffing sequence, doffing technique, or use of appropriate PPE. Common errors were doffing gown from the front, removing face shield of the mask, and touching potentially contaminated surfaces and PPE during doffing. Deviations from the recommended PPE doffing protocol are common and can increase potential for contamination of the HCW’s clothing or skin after providing care. There is a clear need to change the approach used to training HCWs in PPE doffing practices.